Discovery - University of Dundee - Online Publications

Library & Learning Centre

Oncogene

  1. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.

    Sparks, A., Dayal, S., Das, J., Robertson, P., Menendez, S. & Saville, M. K. 18 Sep 2014 In : Oncogene. 33, 38, p. 4685-4696 12 p.

    Research output: Contribution to journalArticle

  2. PDK1 controls upstream PI3K expression and PIP3 generation

    Dieterle, A. M., Böhler, P., Keppeler, H., Alers, S., Berleth, N., Drießen, S., Hieke, N., Pietkiewicz, S., Löffler, A. S., Peter, C., Gray, A., Leslie, N. R., Shinohara, H., Kurosaki, T., Engelke, M., Wienands, J., Bonin, M., Wesselborg, S. & Stork, B. 5 Jun 2014 In : Oncogene. 33, 23, p. 3043-3053 11 p.

    Research output: Contribution to journalArticle

  3. HIF-independent role of prolyl hydroxylases in the cellular response to amino acids

    Durán, R. V., Mackenzie, E. D., Boulahbel, H., Frezza, C., Heiserich, L., Tardito, S., Bussolati, O., Rocha, S., Hall, M. N. & Gottlieb, E. 19 Sep 2013 In : Oncogene. 32, 38, p. 4549-4556 8 p.

    Research output: Contribution to journalArticle

  4. The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage

    Nicol, S. M., Bray, S. E., Derek Black, H., Lorimore, S. A., Wright, E. G., Lane, D. P., Meek, D. W., Coates, P. J. & Fuller-Pace, F. V. 18 Jul 2013 In : Oncogene. 32, 29, p. 3461-3469 9 p.

    Research output: Contribution to journalArticle

  5. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

    Bernard, H., Garmy-Susini, B., Ainaoui, N., Van Den Berghe, L., Peurichard, A., Javerzat, S., Bikfalvi, A., Lane, D. P., Bourdon, J. C. & Prats, A-C. 25 Apr 2013 In : Oncogene. 32, 17, p. 2150-2160 11 p.

    Research output: Contribution to journalArticle

  6. p53 is activated in response to disruption of the pre-mRNA splicing machinery

    Allende-Vega, N., Dayal, S., Agarwala, U., Sparks, A., Bourdon, J-C. & Saville, M. K. 3 Jan 2013 In : Oncogene. 32, 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

  7. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex

    Toska, E., Shandilya, J., Goodfellow, S. J., Medler, K. F. & Roberts, S. G. E. 2013 In : Oncogene.

    Research output: Contribution to journalArticle

  8. Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia

    Ånensen, N., Hjelle, S. M., Van Belle, W., Haaland, I., Silden, E., Bourdon, J-C., Hovland, R., Taskén, K., Knappskog, S., Lønning, P. E., Bruserud, O. & Gjertsen, B. T. 2012 In : Oncogene. 31, 12, p. 1533-1545 13 p.

    Research output: Contribution to journalArticle

  9. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances

    Muller, P., Ruckova, E., Halada, P., Coates, P. J., Hrstka, R., Lane, D. P. & Vojtesek, B. 2012 In : Oncogene.

    Research output: Contribution to journalArticle

  10. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity

    Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A. & Hayes, J. D. 2012 In : Oncogene. 32, p. 3765-3781 17 p.

    Research output: Contribution to journalArticle

  11. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma

    Watt, S., Pourreyron, C., Purdie, K., Hogan, C., Cole, C. L., Foster, N., Pratt, N., Bourdon, J-C., Appleyard, V., Murray, K., Thompson, A., Mao, X., Mein, C., Bruckner-Tuderman, L., Evans, A., McGrath, J. A., Proby, C. M., Foerster, J., Leigh, I. & South, A. Nov 2011 In : Oncogene. 30, 46, p. 4666-4677 12 p.

    Research output: Contribution to journalArticle

  12. Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility

    Preston, R. S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A. B., Dunlop, E. A., Harper, K. T., Brinkhuizen, T., Menko, F. H., Davies, D. M., Land, S. C., Pause, A., Baar, K., van Steensel, M. A. M. & Tee, A. R. 2011 In : Oncogene. 30, 10, p. 1159-1173 15 p.

    Research output: Contribution to journalArticle

  13. Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors

    Dalvai, M., Mondesert, O., Bourdon, J-C., Ducommun, B. & Dozier, C. 2011 In : Oncogene. 30, 19, p. 2282-2288 7 p.

    Research output: Contribution to journalArticle

  14. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

    Henry, L. A., Johnson, D. A., Sarrio, D., Lee, S., Quinlan, P. R., Crook, T., Thompson, A. M., Reis-Filho, J. S. & Isacke, C. M. 2011 In : Oncogene. 30, 9, p. 1046-1058 13 p.

    Research output: Contribution to journalArticle

  15. Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol

    Radulescu, S., Ridgway, R. A., Appleton, P., Kroboth, K., Patel, S., Woodgett, J., Taylor, S., Nathke, I. S. & Sansom, O. J. Dec 2010 In : Oncogene. 29, 49, p. 6418-6427 10 p.

    Research output: Contribution to journalArticle

  16. The RNA helicase p68 modulates expression and function of the Delta 133 isoform(s) of p53, and is inversely associated with Delta 133p53 expression in breast cancer

    Moore, H. C., Jordan, L. B., Bray, S. E., Baker, L., Quinlan, P. R., Purdie, C. A., Thompson, A. M., Bourdon, J-C. & Fuller-Pace, F. V. Dec 2010 In : Oncogene. 29, 49, p. 6475-6484 10 p.

    Research output: Contribution to journalArticle

  17. Enhanced mRNA cap methylation increases Cyclin D1 expression and promotes cell transformation

    Cowling, V. H. 11 Feb 2010 In : Oncogene. 29, 6, p. 930-936 7 p.

    Research output: Contribution to journalArticle

  18. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN

    Davidson, L., Maccario, H., Perera, N. M., Yang, X., Spinelli, L., Tibarewal, P., Glancy, B., Gray, A., Weijer, C. J., Downes, C. P. & Leslie, N. R. 4 Feb 2010 In : Oncogene. 29, 5, p. 687-697 11 p.

    Research output: Contribution to journalArticle

  19. MdmX is a substrate for the deubiquitinating enzyme USP2a

    Allende-Vega, N., Sparks, A., Lane, D. P. & Saville, M. K. 21 Jan 2010 In : Oncogene. 29, 3, p. 432-441 10 p.

    Research output: Contribution to journalArticle

  20. The DEAD-box protein p72 regulates ER alpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ER alpha-positive breast cancer

    Wortham, N. C., Ahamed, E., Nicol, S. M., Thomas, R. S., Periyasamy, M., Jiang, J., Ochocka, A. M., Shousha, S., Huson, L., Bray, S. E., Coombes, R. C., Ali, S. & Fuller-Pace, F. V. 19 Nov 2009 In : Oncogene. 28, 46, p. 4053-4064 12 p.

    Research output: Contribution to journalArticle

  21. Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors

    Cole, M. D. & Cowling, V. H. 5 Mar 2009 In : Oncogene. 28, 9, p. 1169-1175 7 p.

    Research output: Contribution to journalArticle

  22. TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation

    Fleming, Y. M., Ferguson, G. J., Spender, L. C., Larsson, J., Karlsson, S., Ozanne, B. W., Grosse, R. & Inman, G. J. 19 Feb 2009 In : Oncogene. 28, 7, p. 983-993 11 p.

    Research output: Contribution to journalArticle

  23. Understanding PTEN regulation: PIP, polarity and protein stability

    Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L. & Downes, C. P. 15 Sep 2008 In : Oncogene. 27, 41, p. 5464-5476 13 p.

    Research output: Contribution to journalArticle

  24. The regulatory beta-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis

    Yde, C. W., Olsen, B. B., Meek, D., Watanabe, N. & Guerra, B. 28 Aug 2008 In : Oncogene. 27, 37, p. 4986-4997 12 p.

    Research output: Contribution to journalArticle

  25. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer

    McCracken, S. R. C., Ramsay, A., Heer, R., Mathers, M. E., Jenkins, B. L., Edwards, J., Robson, C. N., Marquez, R., Cohen, P. & Leung, H. Y. 8 May 2008 In : Oncogene. 27, 21, p. 2978-2988 11 p.

    Research output: Contribution to journalArticle

  26. An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II

    Cowling, V. H. & Cole, M. D. 21 Feb 2008 In : Oncogene. 27, 9, p. 1327-1332 6 p.

    Research output: Contribution to journalArticle

  27. Drosophila asymmetric division, polarity and cancer

    Januschke, J. & Gonzalez, C. 2008 In : Oncogene. 27, 55, p. 6994-7002 9 p.

    Research output: Contribution to journalArticle

  28. Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling

    Lackey, J., Barnett, J., Davidson, L., Batty, I. H., Leslie, N. R. & Downes, C. P. Nov 2007 In : Oncogene. 26, 50, p. 7132-7142 11 p.

    Research output: Contribution to journalArticle

  29. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1

    Jacobs, A-M., Nicol, S. M., Hislop, R. G., Jaffray, E. G., Hay, R. T. & Fuller-Pace, F. V. 30 Aug 2007 In : Oncogene. 26, 40, p. 5866-76 11 p.

    Research output: Contribution to journalArticle

  30. Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1

    Roche, K. C., Rocha, S., Bracken, C. P. & Perkins, N. D. 5 Jul 2007 In : Oncogene. 26, 31, p. 4523-30 8 p.

    Research output: Contribution to journalArticle

  31. Highlights of the 23rd Genes and Cancer meeting University of Warwick 11-13 December 2006

    Labib, K. 26 Apr 2007 In : Oncogene. 26, 19, p. 2675-2677 3 p.

    Research output: Contribution to journalEditorial

  32. HIF-1α contributes to tumour-selective killing by the sigma receptor antagonist rimcazole

    Achison, M., Boylan, M. T., Hupp, T. R. & Spruce, B. A. 22 Feb 2007 In : Oncogene. 26, 8, p. 1137-1146 10 p.

    Research output: Contribution to journalArticle

  33. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases

    Owens, D. M. & Keyse, S. M. 2007 In : Oncogene. 26, 22, p. 3203-13 11 p.

    Research output: Contribution to journalArticle

  34. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation

    Cowling, V. H. & Cole, M. D. 2007 In : Oncogene. 26, 24, p. 3582-6 5 p.

    Research output: Contribution to journalArticle

  35. Evaluation of the 3p21.3 tumour-suppressor gene cluster

    Hesson, L. B., Cooper, W. N. & Latif, F. 2007 In : Oncogene. 26, 52, p. 7283-7301 19 p.

    Research output: Contribution to journalArticle

  36. Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

    Allende-Vega, N., Saville, M. K. & Meek, D. W. 2007 In : Oncogene. 26, 29, p. 4234-4242 9 p.

    Research output: Contribution to journalArticle

  37. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6

    Camus, S., Menendez, S., Cheok, C. F., Stevenson, L. F., Lain, S. & Lane, D. P. 2007 In : Oncogene. 26, 28, p. 4059-4070 12 p.

    Research output: Contribution to journalArticle

  38. A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design

    Warbrick, E. 2006 In : Oncogene. 25, 20, p. 2850-2859 10 p.

    Research output: Contribution to journalArticle

  39. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF

    Dias, S. S., Milne, D. M. & Meek, D. W. 2006 In : Oncogene. 25, 50, p. 6666-6671 6 p.

    Research output: Contribution to journalArticle

  40. The 'regulatory' β-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation

    Bjørling-Poulsen, M., Siehler, S., Wiesmüller, L., Meek, D., Niefind, K. & Issinger, O-G. 8 Sep 2005 In : Oncogene. 24, 40, p. 6194-6200 7 p.

    Research output: Contribution to journalArticle

  41. Wild-type p53 activates SAP expression in lymphoid cells

    Nagy, N., Takahara, M., Nishikawa, J., Bourdon, J. C., Kis, L. L., Klein, G. & Klein, E. 2004 In : Oncogene. 23, 53, p. 8563-8570 8 p.

    Research output: Contribution to journalArticle

  42. Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target

    Tullo, A., Mastropasqua, G., Bourdon, J. C., Centonze, P., Gostissa, M., Costanzo, A., Levrero, M., Del Sal, G., Saccone, C. & Sbisa, E. 27 Nov 2003 In : Oncogene. 22, 54, p. 8738-8748 11 p.

    Research output: Contribution to journalArticle

  43. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX

    Mac Partlin, M., Homer, E., Robinson, H., McCormick, C. J., Crouch, D. H., Durant, S. T., Matheson, E. C., Hall, A. G., Gillespie, D. A. F. & Brown, R. Feb 2003 In : Oncogene. 22, 6, p. 819-825 7 p.

    Research output: Contribution to journalArticle

  44. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation

    Lorimore, S. A., Coates, P. J. & Wright, E. G. 2003 In : Oncogene. 22, 45, p. 7058-69 12 p.

    Research output: Contribution to journalScientific review

  45. Cell type-specific responses of human cells to inhibition of replication licensing

    Shreeram, S., Sparks, A., Lane, D. P. & Blow, J. J. 2002 In : Oncogene. 21, 43, p. 6624-6632 9 p.

    Research output: Contribution to journalArticle

  46. Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours

    Causevic, M., Hislop, R. G., Kernohan, N. M., Carey, F. A., Kay, R. A., Steele, R. J. C. & Fuller-Pace, F. V. Nov 2001 In : Oncogene. 20, 53, p. 7734-7743 10 p.

    Research output: Contribution to journalArticle

  47. Induction of endogenous β-galactosidase by ionizing radiation complicates the analysis of p53-LacZ transgenic mice

    Coates, P., Lorimore, S., Rigat, B. A., Lane, D. & Wright, E. Oct 2001 In : Oncogene. 20, 48, p. 7096-7097 2 p.

    Research output: Contribution to journalArticle

  48. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo

    Xirodimas, D., Saville, M. K., Edling, C., Lane, D. & Lain, S. 2001 In : Oncogene. 20, 36, p. 4972-4983 12 p.

    Research output: Contribution to journalArticle

  49. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo

    Wallace, M., Coates, P. J., Wright, E. G. & Ball, K. L. 2001 In : Oncogene. 20, 28, p. 3597-3608 12 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next

Library & Learning Centre

Contact | Accessibility | Policy